Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William L Daley is active.

Publication


Featured researches published by William L Daley.


Circulation | 1996

TIMI Frame Count A Quantitative Method of Assessing Coronary Artery Flow

Cm Gibson; Christopher P. Cannon; William L Daley; Dodge Jt; Brian M. Alexander; Susan J. Marble; Carolyn H. McCabe; Raymond L; Terry Fortin; Poole Wk; Eugene Braunwald

BACKGROUND Although the Thrombolysis in Myocardial Infarction (TIMI) flow grade is valuable and widely used qualitative measure in angiographic trials, it is limited by its subjective and categorical nature. METHODS AND RESULTS In normal patients and patients with acute myocardial infarction (MI) (TIMI 4), the number of cineframes needed for dye to reach standardized distal landmarks was counted to objectively assess an index of coronary blood flow as a continuous variable. The TIMI frame-counting method was reproducible (mean absolute difference between two injections, 4.7 +/- 3.9 frames, n=85). In 78 consecutive normal arteries, the left anterior descending coronary artery (LAD) TIMI frame count (36.2 +/- 2.6 frames) was 1.7 times longer than the mean of the right coronary artery (20.4 +/- 3.0) and circumflex counts (22.2 +/- 4.1, P < .001 for either versus LAD). Therefore, the longer LAD frame counts were corrected by dividing by 1.7 to derive the corrected TIMI frame count (CTFC). The mean CTFC in culprit arteries 90 minutes after thrombolytic administration followed a continuous unimodal distribution (there were not subpopulations of slow and fast flow) with a mean value of 39.2 +/- 20.0 frames, which improved to 31.7 +/- 12.9 frames by 18 to 36 hours (P < .001). No correlation existed between improvements in CTFCs and changes in minimum lumen diameter (r=-.05, P=.59). The mean 90-minute CTFC among nonculprit arteries (25.5 +/- 9.8) was significantly higher (flow was slower) compared with arteries with normal flow in the absence of acute MI (21.0 +/- 3.1, P < .001) but improved to that of normal arteries by 1 day after thrombolysis (21.7 +/- 7.1, P=NS). CONCLUSIONS The CTFC is a simple, reproducible, objective and quantitative index of coronary flow that allows standardization of TIMI flow grades and facilitates comparisons of angiographic end points between trials. Disordered resistance vessel function may account in part for reductions in flow in the early hours after thrombolysis.


American Journal of Cardiology | 1997

Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow

C. Michael Gibson; J.Theodore Dodge; Mukesh Goel; Eyas N Al-Mousa; Michael Rizzo; Christine McLean; Kathryn A. Ryan; Anthony Sparano; Susan J. Marble; William L Daley; Christopher P. Cannon; Elliott M. Antman

The Thrombolysis In Myocardial Infarction (TIMI) frame count is a relative index of coronary flow that measures time by counting the number of frames required for dye to travel from the ostium to a standardized coronary landmark in a cineangiogram filmed at a known speed (frames/s). We describe a new method to measure distance along arteries so that absolute velocity (length divided by time) and absolute flow (area x velocity) may be calculated in patients undergoing percutaneous transluminal coronary angiography (PTCA). After PTCA, the guidewire tip is placed at the coronary landmark and a Kelly clamp is placed on the guidewire where it exits the Y-adapter. The guidewire tip is then withdrawn to the catheter tip and a second Kelly clamp is placed on the wire where it exits the Y-adapter. The distance between the 2 Kelly clamps outside the body is the distance between the catheter tip and the anatomic landmark inside the body. Velocity (cm/s) may be calculated as this distance (cm) divided by TIMI frame count (frames) x film frame speed (frames/s). Flow (ml/s) may be calculated by multiplying this velocity (cm/s) and the mean cross-sectional lumen area (cm2) along the length of the artery to the TIMI landmark. In 30 patients, velocity increased from 13.9 +/- 8.5 cm/s before to 22.8 +/- 9.3 cm/s after PTCA (p <0.001). Despite TIMI grade 3 flow both before and after PTCA in 18 patients, velocity actually increased 38%, from 17.0 +/- 5.4 to 23.5 +/- 9.0 cm/s (p = 0.01). For all 30 patients, flow doubled from 0.6 +/- 0.4 ml/s before to 1.2 +/- 0.6 ml/s after PTCA (p <0.001). In the 18 patients with TIMI grade 3 flow both before and after PTCA, flow increased 86%, from 0.7 +/- 0.3 to 1.3 +/- 0.6 ml/s (p = 0.001). Distance along coronary arteries (length) can be simply measured using a PTCA guidewire. This length may be combined with the TIMI frame count to calculate measures of absolute velocity and flow that are sensitive to changes in perfusion. TIMI grade 3 flow is composed of a range of velocities and flows.


Journal of Thrombosis and Thrombolysis | 1998

The Open Artery Hypothesis: Past, Present, and Future.

Mukesh Goel; J. Theodore DodgeJr.; Michael Rizzo; Christine McLean; Kathryn A. Ryan; William L Daley; Christopher P. Cannon; C. Michael Gibson

The survival benefit following a reperfusion strategy, be it pharmacologic or mechanical, appears to be due to both full and early reperfusion. While the TIMI Flow Grade classification scheme has been a useful tool to assess coronary blood flow in acute syndromes, it has several limitations. A newer method of assessing coronary blood flow called the Corrected TIMI Frame Count method has the following advantages: (1) it is a continuous quantitative variable rather than a categorical qualitative variable; (2) the flow in the non-culprit artery is not assumed to be normal as it is in the assessment of TIMI Grade 3 Flow; (3) there is simplified reporting of reperfusion efficacy through the use of a single number instead of expressing the data in 2 to 4 categories; (4) because a single number rather than 4 categories is used to report the data, there is more efficient use of the dataset by increasing the statistical power; and finally (5) coronary flow can be expressed in intuitive terms (e.g. time or cm/sec for strategy A versus time or cm/sec for strategy B). This paper reviews the history of the open artery hypothesis and recent advances in the field.


American Heart Journal | 1998

Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts

Eyas N Al-Mousa; J.Theodore Dodge; Michael Rizzo; Christine McLean; Kathryn A. Ryan; John Moynihan; Michael P. Kelley; Susan J. Marble; Mukesh Goel; William L Daley; C. Michael Gibson


Journal of Interventional Cardiology | 1996

Techniques in the Angiographic Analysis of Coronary Flow: Past, Present, and Future

Imran Dotani; Theodore Dodge; Mukesh Goel; Eyas N Al-Mousa; Christine McLean; Michael Rizzo; Kathryn A. Ryan; Ralph Vatner; Susan J. Marble; William L Daley; C. Michael Gibson


/data/revues/00029149/v86i1/S0002914900008407/ | 2011

Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

Norman Lepor; Stacey B. Gross; William L Daley; Bruce Samuels; Michael Rizzo; Sean P Luko; Ann Hickey; Neil A. Buchbinder; Tasneem Z. Naqvi


Circulation | 2007

Abstract 2280: Urine Albumin/creatinine Ratio, Cardiac Structure And Diastolic Function In Patients With Hypertension And Diastolic Dysfunction: The Validd Study

Anil Verma; Rajesh Janardhanan; William L Daley; Susan Ritter; William Kaye; Tasneem Z. Naqvi; Yves Lacourcier; Gerard P. Aurigemma; James D. Thomas; Michael R. Zile; Scott D. Solomon


Circulation | 2007

Abstract 625: Low Endothelial Shear Stress Promotes the Differentiation of Early Atherosclerotic Lesions to Thin Cap Fibroatheromas

Yiannis S. Chatzizisis; Michael Jonas; Ahmet U. Coskun; Roy Beigel; Benjamin V. Stone; Charles Maynard; Ross G. Gerrity; William L Daley; Campbell Rogers; Elazer R. Edelman; Charles L. Feldman; Peter H. Stone


Circulation | 2007

Abstract 3398: Comparison of Once Versus Twice a Day Valsartan Dosing in Heart Failure -Results of the DESTINY Trial

Inder S. Anand; Anita Deswal; Alan Steljes; Dion H. Zappe; William L Daley


Circulation | 2006

Abstract 2543: Left Ventricular Diastolic Function in a Broad Range of Patients with Hypertension: The Valsartan in Diastolic Dysfunction (VALIDD) Trial

Rajesh Janardhanan; William L Daley; Michael R. Zile; Gerard P. Aurigemma; Tasneem Z. Naqvi; Yves Lacourcière; Stephen Hippler; Harold Fields; William Kaye; Susan Ritter; James D. Thomas; Malcolm Arnold; Scott D. Solomon

Collaboration


Dive into the William L Daley's collaboration.

Top Co-Authors

Avatar

Michael Rizzo

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

C. Michael Gibson

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Christine McLean

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Kathryn A. Ryan

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Mukesh Goel

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eyas N Al-Mousa

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gerard P. Aurigemma

University of Massachusetts Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge